CD1E Inhibitors
CD1E inhibitors encompass a range of chemical compounds that impede the protein's ability to present lipid antigens, which is central to its role in immune surveillance. Staurosporine, through its broad kinase inhibition, impairs the phosphorylation of proteins vital for CD1E's intracellular maturation and trafficking, resulting in its diminished antigen-presenting function. Brefeldin A and Monensin disrupt the Golgi apparatus, where post-translational modifications of CD1E are crucial, thereby leading to an impaired maturation process and a consequent reduction in its function. Chloroquine and Ammonium chloride both increase the pH of endosomal and lysosomal compartments, a step that is vital for the enzymatic processing of lipid antigens, ultimately leading to a deficiency in CD1E's capacity to present these antigens. U 18666A and Filipin interfere with cholesterol trafficking and lipid raft integrity, respectively, further undermining the antigen-presenting efficiency of CD1E by altering the vesicle trafficking and cellular membrane composition that are essential for its function.
Moreover, Progesterone indirectly affects CD1E by modulating the cytokine environment, altering the immune response balance, and potentially reducing the expression or function of antigen-presenting molecules. GW4869 targets the sphingomyelin-ceramide pathway, essential for vesicle formation and trafficking, which is integral to CD1E's lipid antigen presentation. 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline disrupts cellular energetics, thereby impairing the energy-dependent processes crucial for CD1E's endosomal and lysosomal antigen processing. Genistein's inhibition of tyrosine kinases could reduce necessary phosphorylation events for CD1E trafficking and function, while Cytochalasin D's actin disruption could hinder the intracellular transport and surface expression of CD1E, further diminishing its antigen-presenting capabilities. Collectively, these inhibitors manifest their effects by targeting the specific biochemical and cellular pathways upon which CD1E depends for its activity, thereby leading to its functional inhibition.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent non-selective inhibitor of protein kinases. In the context of CD1E, staurosporine can inhibit kinases that phosphorylate proteins involved in the antigen presentation process, potentially diminishing the functional activity of CD1E by preventing its proper maturation or trafficking within the cell. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is an inhibitor of ADP-ribosylation factor (ARF), a small GTPase involved in vesicle trafficking. By disrupting ARF function, Brefeldin A can lead to the disassembly of the Golgi apparatus, which is essential for the loading of lipid antigens onto CD1E molecules; hence, it diminishes CD1E-mediated antigen presentation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to raise the pH of acidic intracellular vesicles, such as endosomes and lysosomes. This increase in pH can inhibit the enzymatic processing of lipid antigens necessary for loading onto CD1E, thereby diminishing the functional activity of CD1E in antigen presentation. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
U 18666A is a cholesterol transport inhibitor that can induce the accumulation of unesterified cholesterol in late endosomes and lysosomes. This disruption of cholesterol trafficking can impair the ability of CD1E to load lipid antigens properly, thereby reducing its functional activity. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a sodium ionophore that disrupts Golgi function by altering cation homeostasis. As the Golgi apparatus is involved in the post-translational modification of CD1E, monensin can impair the functional maturation of CD1E and thus diminish its role in antigen presentation. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Filipin is a polyene macrolide that binds to cholesterol, disrupting lipid rafts within the cellular membrane. Since CD1E is dependent on lipid raft integrity for its trafficking and antigen presentation, the binding of filipin can diminish the functional activity of CD1E. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone can modulate the immune response by affecting the balance of Th1/Th2 cells. It can potentially diminish the functional activity of CD1E by indirectly influencing the cytokine milieu which affects the expression and function of molecules involved in antigen presentation. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 is an inhibitor of neutral sphingomyelinase (nSMase), an enzyme involved in ceramide production. Since ceramide is implicated in vesicle formation and trafficking, inhibiting nSMase with GW4869 could diminish the ability of CD1E to present lipid antigens by altering vesicle trafficking. | ||||||
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline | 90-34-6 | sc-483239 | 1 g | $360.00 | 1 | |
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline interferes with the electron transport chain in mitochondria, affecting cellular energetics. By disrupting energy-dependent processes, primaquine can diminish the endosomal and lysosomal functions necessary for the proper loading and presentation of antigens by CD1E. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can interfere with a variety of cell signaling pathways. By inhibiting tyrosine kinases, genistein may diminish the phosphorylation events necessary for the trafficking and antigen presentation activity of CD1E. | ||||||